How to Help Your Patients Save Money on Lumigan: A Provider's Guide to Savings Programs

Medication adherence in glaucoma is directly tied to vision preservation. When patients can't afford Lumigan (bimatoprost), they skip doses, stretch bottles, or abandon treatment entirely — all of which allow intraocular pressure to rise and optic nerve damage to progress. This guide equips prescribers with the practical knowledge needed to connect patients with every available savings resource for Lumigan in 2026.

Why Lumigan Cost Is a Significant Adherence Barrier

Brand Lumigan 0.01% costs $200–$300+ per bottle at full retail — and for many patients on Medicare, Medicaid, or high-deductible plans, even generic bimatoprost at $67–$274 per bottle represents a serious financial burden. Glaucoma is a lifelong condition; these costs accumulate year over year. Multiple studies have demonstrated that out-of-pocket medication costs are among the top predictors of non-adherence in glaucoma patients.

Understanding each patient's insurance status and financial situation at the time of prescribing — and proactively connecting them to the appropriate savings resource — can meaningfully improve long-term adherence and outcomes.

Program 1: AbbVie At Your Service (AYS) Co-Pay Savings Card

The AbbVie At Your Service (AYS) co-pay assistance program is the most commonly applicable savings program for commercially insured Lumigan patients.

Benefit: Up to $2,640 per calendar year in co-pay savings for brand Lumigan

Eligibility: Patients with commercial (private) insurance; NOT eligible if covered by Medicare, Medicaid, TRICARE, or other government-funded plans

Enrollment: Patients or prescribing office staff can enroll at savewithays.com

How to use: Patient presents the AYS savings card at pharmacy pickup; savings are applied at point of sale

Clinical tip: Consider adding the AYS enrollment URL to your new prescription printouts for all patients starting brand Lumigan. This takes less than 5 minutes for a patient to complete online and can reduce a $300+ monthly cost to near zero.

Program 2: myAbbVie Assist Patient Assistance Program (PAP)

For patients who are uninsured or underinsured and cannot afford Lumigan at any price, the myAbbVie Assist PAP provides brand-name Lumigan at no cost to eligible patients who meet income and insurance criteria.

Benefit: Free brand-name Lumigan for eligible patients

Eligibility: Uninsured or underinsured; income requirements apply (vary by household size); not available for patients who have insurance covering Lumigan

Application process: Apply at abbvie.com/patients/patient-assistance-program, or your office can submit the application. Applications typically require proof of income, confirmation of insurance status, and a signed prescription from the treating physician.

Turnaround: Processing typically takes 2–4 weeks. For urgent cases, contact AbbVie directly.

Clinical tip: Identify patients who may qualify (uninsured, recently unemployed, underinsured with high-deductible plans) at the time of prescription, and have a medical assistant initiate the application before the patient leaves the office. This greatly increases follow-through compared to asking patients to apply on their own.

Program 3: Prescription Discount Cards (GoodRx, SingleCare)

For patients who do not qualify for manufacturer programs (e.g., Medicare Part D patients), prescription discount cards offer meaningful savings on generic bimatoprost:

GoodRx: Generic bimatoprost 0.03% as low as $18–$78 depending on pharmacy and bottle size; 70%+ savings off retail

SingleCare: Generic bimatoprost 0.03% (5 mL) for approximately $57 at many pharmacies

Key point for providers: GoodRx coupons CANNOT be combined with Medicare Part D. Patients on Medicare who use a GoodRx coupon are choosing to pay out-of-pocket instead of using insurance — and this does not count toward their Medicare deductible or out-of-pocket maximum. For some patients, a GoodRx coupon may still be cheaper than their Part D co-pay, especially for generic bimatoprost. Help patients calculate which is lower.

Program 4: Medicare Extra Help / Low-Income Subsidy

For Medicare Part D patients who struggle with drug costs, the Extra Help (Low-Income Subsidy) program significantly reduces premiums, deductibles, and co-pays. Patients who qualify may pay as little as $4–$10 for generic bimatoprost per fill.

Eligibility: Income and asset limits apply; most patients at or below 150% of the federal poverty level qualify

Apply through Social Security at ssa.gov/extrahelp or through the State Health Insurance Assistance Program (SHIP)

The Generic Switch: The Most Cost-Effective Prescription Change You Can Make

For patients who cannot access savings programs or who are on Medicare without extra help, switching from brand Lumigan 0.01% to generic bimatoprost 0.03% remains the single most powerful cost-reduction tool available. With GoodRx, generic bimatoprost can cost under $78 per month — versus $200–$300+ for the brand.

Clinical considerations for concentration switch (0.01% → 0.03%):

Conjunctival hyperemia may increase slightly with 0.03% formulation in some patients — set expectations

Eyelash growth may be more pronounced with 0.03%

IOP reduction is comparable; schedule a follow-up IOP check 4–6 weeks after the switch to confirm continued efficacy

When to Consider Latanoprost Instead: Affordability Ladder

If cost remains a barrier even with discount coupons, consider the affordability ladder:

Generic bimatoprost 0.03% + GoodRx: ~$18–$78/month

Generic latanoprost 0.005% + GoodRx: ~$10–$25/month — nearly identical efficacy for most patients; nearly universally stocked

Generic timolol 0.5% + GoodRx: ~$5–$15/month — different mechanism; lower IOP reduction (~20%); requires cardiac/pulmonary screening

Integrating Savings Conversations Into Clinical Workflow

Practical workflow recommendations:

Screen all new Lumigan patients for insurance type at the time of prescribing (commercial, Medicare, Medicaid, uninsured)

Route commercially insured patients to AYS co-pay card enrollment (savewithays.com)

Route uninsured/underinsured patients to myAbbVie Assist PAP; initiate in-office if possible

For Medicare patients, share GoodRx generic bimatoprost prices and refer to Extra Help if applicable

If cost remains prohibitive after all programs, discuss generic latanoprost as an affordable, evidence-based alternative

medfinder also supports your patients between appointments. When patients can't find or afford their Lumigan, refer them to medfinder to locate a pharmacy with it in stock and compare prices.

See also: How to help your patients find Lumigan in stock: A provider's guide.